<div class="container">

<table style="width: 100%;"><tr>
<td>DLBCL</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Chemotherapy data</h2>

<h3>Description</h3>

<p>A list of two components.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(DLBCL)
</code></pre>


<h3>Format</h3>

<p>A list with two components: 
</p>

<dl>
<dt>Y</dt>
<dd>
<p>Chromatin immunoprecipitation. A matrix of 180 rows and 661 columns.</p>
</dd>
<dt>classIndex</dt>
<dd>
<p>Group index of 180 patients where <em>1,2,3</em> corresponds to OxPhos, BCR and HR groups respectively.</p>
</dd>
</dl>
<h3>Details</h3>

<p>Matrix Y : Gene expression dataset from the patients with diffuse large-B-cell lymphoma (DLBCL) after chemotherapy.
The data has been used for unsupervised analysis i.e. Biclustering. The data consists of expression levels of q = 661 genes from n =180 patients. Among the patients, 42, 51 and
87 of them were classified to OxPhos, BCR and HR groups, respectively. The data thus
form an n by q matrix Y whose rows represent the subjects and columns correspond to the
genes, and used in Rosenwald (2002).
</p>
<p>classIndex: Out of OxPhos (oxidative phosphorylation), BCR(Bcell response) and HR (host response),
the index corresponds to the groups in which these 180 subjects belongs as classified by Hoshida (2007).
</p>


<h3>References</h3>

<p>Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., 
Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M. et al. (2002) <em>The
use of molecular profling to predict survival after chemotherapy for diffuse large-b-cell
lymphoma. New England Journal of Medicine, 346, 1937-1947</em>.
</p>
<p>Hoshida, Y., Brunet, J.-P., Tamayo, P., Golub, T. R. and Mesirov, J. P. (2007) <em>Subclass
mapping: Identifying common subtypes in independent disease data sets. PLoS ONE, 2,
e1195</em>.
</p>


<h3>Examples</h3>

<pre><code class="language-R"># data(DLBCL)
</code></pre>


</div>